Patent ID: 11883388
Assignee: SEN-JAM PHARMACEUTICAL INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of inhibiting the symptoms associated with viral upper respiratory tract infection, consisting of:
administering an effective amount of a pharmaceutical composition to a subject at risk of acquiring the viral upper respiratory tract infection, and before viral upper respiratory tract symptoms appear, wherein the active ingredients of the pharmaceutical composition consist of:
a) a non-steroidal anti-inflammatory drug (NSAID), and/or a salt thereof; and
b) a co-agent selected from the group consisting of: fexofenadine, ketotifen, desloratadine, salts thereof, and combinations thereof;
wherein the pharmaceutical composition does not include a decongestant, and
wherein the symptoms associated with the viral upper respiratory tract infection are inhibited.